Addendum: Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial
Crossref DOI link: https://doi.org/10.1038/s41467-025-63690-x
Published Online: 2025-09-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ninmer, Emily K.
Zhu, Hong
Chianese-Bullock, Kimberly A.
von Mehren, Margaret
Haas, Naomi B.
Ross, Merrick I.
Dengel, Lynn T.
Slingluff, Craig L. Jr
Text and Data Mining valid from 2025-09-05
Version of Record valid from 2025-09-05
Article History
First Online: 5 September 2025